FDA 510k Summary and Statement

FDA 510k Summary or Statement is part of the 510k file of a medical device that requires the Premarket notification from the FDA for the marketing authorization in the US market.

510k Summary contains the summary of information on the characteristics of the subject device on which the Substantial Equivalence is claimed. 510k statement is the declaration of the manufacturer of the medical device that they will provide the information supporting the safety and effectiveness approved by the FDA to Any person within 30 days on the written request.

The manufacturer has to make the choice between the 510k summary or statement that should be made before the 510k is submitted.

Once the Substantial equivalence is determined, they can not change the choice of statement or summary. The content required to be included in a summary is as per 21 CFR 807.92 and the Statement is as per 21 CFR 807.93. Once the 510k file is approved by the FDA the summary will be publicly available on the FDA website.

FDA 510k Executive Summary

A 510k Summary provides a brief summary of the device included in the premarket notification and the supporting information. It must be in sufficient detail to provide an understanding of the basis for a determination of substantial equivalence.

The summary should be a separate section for the submission. It contains, the 510k owner’s name, address, phone and fax numbers, name of contact person, and date the summary was prepared, the name of the device, including the trade or proprietary name, if applicable, the common or usual name, and the classification name. The summary shall prepare on the letterhead of the organization.

The summary shall contain the following information but not limited to.

  • ~ Intended use.
  • ~ Device description
  • ~ General characteristics of the device
  • ~ Performance tests, bench tests, non-clinical/ clinical tests.
  • ~ Comparison table with predicate
  • ~ the determination of substantial equivalence
  • ~ conclusion

510k Executive Summary / Predicate Comparison is a section of 510k which should include,

  • concise description of the device, including the indications for use and technology.
  • device comparison table; and
  • concise summary for any performance testing in the submission.

The information should be sufficient to understand the device. The comparison table shall discuss the similarities and dissimilarities of the device and the predicate device.

Are you looking for an FDA 510k submission? We can help with it! Contact us for more details or fill out the RFQ for a detailed proposal with a statement of work

Quick Contact